EUCTR2011-006244-73-ES
Active, not recruiting
Not Applicable
Evaluation of the efficacy of memantine in the treatment of fibromyalgia: a double-blind randomized control clinical trial.
Instituto Aragonés de Ciencias de la Salud0 sitesApril 12, 2012
DrugsEbixa
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Status
- Active, not recruiting
- Last Updated
- 13 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 60
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Assessment the effect of memantine in the treatment of chemotherapy-induced peripheral neuropathychemotherapy-induced peripheral neuropathy in patients with cancer.Idiopathic peripheral autonomic neuropathyG90.0IRCT20160310026998N12Tabriz University of Medical Sciences180
Completed
Phase 2
Memantine effect in the treatment of residual symptoms in patients with schizophreniaIRCT2017013032236N2Vice chancellor for research, Mazandaran University of Medical Sciences50
Not yet recruiting
Not Applicable
An investigation on the effect of memantine on children with autistic spectrum disorderIRCT20211118053097N1Shiraz University of Medical Sciences52
Completed
Phase 3
Evaluation of the effect of memantine for the prevention of headaches caused by head traumapost traumatic headache.post traumatic headacheG44.3IRCT20201005048944N1Esfahan University of Medical Sciences90
Completed
Not Applicable
Investigation on efficacy of memantine in patients with Alzheimer's disease.Alzheimer's diseaseJPRN-UMIN000011392Kawasaki Medical School50